Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-242.1%-88.2pp-202.1%-48.7pp-173.4%-14.6pp-159.8%-4.5pp-153.9%+2.1pp
Return on invested capital-290.8%-75.2pp-247.5%-26.1pp-219.9%+10.7pp-216.1%+15.5pp-215.5%+17.4pp
Liquidity
Current ratio33.8×-23.5×40.4×-21.9×47.5×-13.7×53.7×-2.9×57.3×+4.4×
Leverage
Debt-to-equity0.4×+0.1×0.3×+0.1×0.3×+0.1×0.3×0.0×0.2×0.0×
Per Share
Book value per share$34.48-21.2%$37.96-12.1%$42.88-6.4%$43.83-0.6%$43.74+1.7%
Valuation
Market capitalization$50.86B+77.6%$38.16B+39.4%$30.84B+32.2%$29.68B+57.9%$28.63B+87.1%
Price / book31.8×+16.2×22.1×+6.6×16.2×+2.1×15.6×+2.7×15.5×+3.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Revolution Medicines, Inc.'s ratios come from?
Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.